• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助化疗中浸润性导管乳腺癌的肿瘤纹理参数:乳腺 MRI 上早期识别无应答者。

Tumor texture parameters of invasive ductal breast carcinoma in neoadjuvant chemotherapy: early identification of non-responders on breast MRI.

机构信息

Institute of Oncology and Radiology of Serbia, Clinic for Radiology and Radiation Oncology, Dept. of Radiology, Dept. of Breast Imaging, School of Medicine, University of Belgrade, Belgrade, Serbia.

Institute of Oncology and Radiology of Serbia, Clinic for Radiology and Radiation Oncology, Dept. of Radiology, Dept. of Breast Imaging, School of Medicine, University of Belgrade, Belgrade, Serbia.

出版信息

Clin Imaging. 2020 Sep;65:119-123. doi: 10.1016/j.clinimag.2020.04.016. Epub 2020 Apr 21.

DOI:10.1016/j.clinimag.2020.04.016
PMID:32446129
Abstract

PURPOSE

Texture analysis (TA) parameters (variance of SI, mean of gradient, variance of gradient, kurtosis of SI, and entropy) in patients with invasive ductal carcinoma (IDC) contribute to objective assessment of neoadjuvant chemotherapy (NACT) activity. The objective was to assess TA parameters in early identification of non-responders (NR) in NACT, after the 2nd cycle of NACT.

MATERIAL AND METHODS

Fifty patients (N = 50) were included in the retrospective analysis of baseline and MRI following the 2nd cycle of NACT. TA parameters were computed and correlated to the lesion size and DWI-ADC in NR (N1 = 25). Additional matched responders (R, N2 = 25) assessed for the same parameters, served as the control group.

RESULTS

Tumor size and ADC did not change significantly in NR after the 2nd cycle of NACT (2.88 ± 0.38 vs. 2.76 ± 0.36 [cm], p = 0.131; 1.01 ± 0.14 vs. 1.05 ± 0.13 [mm/s × 10], p = 0.363), but TA parameters changed significantly: variance of gradient (346.5 ± 12.6 vs. 355.6 ± 16.9, p = 0.01), kurtosis of SI (1.47 ± 0.09 vs. 1.54 ± 0.11, p = 0.02), entropy LH (60.39 ± 4.34 vs. 64.42 ± 3.05, p = 0.001) and entropy HL (61.02 ± 5.51 vs. 65.63 ± 3.63, p < 0.00001). TA parameters, particularly entropy (EN LH 64.42 ± 3.05 vs. 61.59 ± 1.76, p < 0.0001; EN HL 65.63 ± 3.63 vs. 62.89 ± 2.05, p < 0.0001), significantly differ between NR and R in early response assessment.

CONCLUSION

Entropy, kurtosis of SI and variance of gradient tend to increase in NR. TA parameters significantly differ between NR and R after the 2nd cycle of NACT. TA parameters, related to morpho-functional parameters may contribute to early NR identification.

摘要

目的

在接受新辅助化疗(NACT)的患者中,纹理分析(TA)参数(SI 的方差、梯度的均值、梯度的方差、SI 的峰度和熵)有助于对 NACT 活性进行客观评估。本研究旨在评估 TA 参数在 NACT 第 2 周期后早期识别无反应者(NR)中的作用。

材料和方法

回顾性分析了 50 例基线和 NACT 第 2 周期后 MRI 的患者(N=50)。计算 TA 参数,并与 NR(N1=25)的病变大小和 DWI-ADC 相关。另外,对 25 例匹配的反应者(R)评估了相同的参数,作为对照组。

结果

NR 患者在 NACT 第 2 周期后肿瘤大小和 ADC 无明显变化(2.88±0.38 对比 2.76±0.36 [cm],p=0.131;1.01±0.14 对比 1.05±0.13 [mm/s×10],p=0.363),但 TA 参数明显变化:梯度方差(346.5±12.6 对比 355.6±16.9,p=0.01)、SI 峰度(1.47±0.09 对比 1.54±0.11,p=0.02)、LH 熵(60.39±4.34 对比 64.42±3.05,p=0.001)和 HL 熵(61.02±5.51 对比 65.63±3.63,p<0.00001)。TA 参数,特别是熵(EN LH 64.42±3.05 对比 61.59±1.76,p<0.0001;EN HL 65.63±3.63 对比 62.89±2.05,p<0.0001),在早期反应评估中 NR 和 R 之间差异显著。

结论

NR 中熵、SI 峰度和梯度方差有增加趋势。NACT 第 2 周期后,NR 和 R 之间 TA 参数差异显著。与形态功能参数相关的 TA 参数可能有助于早期识别 NR。

相似文献

1
Tumor texture parameters of invasive ductal breast carcinoma in neoadjuvant chemotherapy: early identification of non-responders on breast MRI.新辅助化疗中浸润性导管乳腺癌的肿瘤纹理参数:乳腺 MRI 上早期识别无应答者。
Clin Imaging. 2020 Sep;65:119-123. doi: 10.1016/j.clinimag.2020.04.016. Epub 2020 Apr 21.
2
[Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].磁共振图像纹理分析在预测直肠癌新辅助放化疗疗效中的应用价值
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Sep 25;21(9):1051-1058.
3
Response to neoadjuvant treatment of invasive ductal breast carcinomas including outcome evaluation: MRI analysis by an automatic CAD system in comparison to visual evaluation.浸润性导管癌新辅助治疗的反应包括疗效评估:自动计算机辅助检测系统与视觉评估对比的MRI分析
Acta Oncol. 2014 Jun;53(6):759-68. doi: 10.3109/0284186X.2013.852688. Epub 2013 Dec 3.
4
Diffusional kurtosis imaging for differentiation of additional suspicious lesions on preoperative breast MRI of patients with known breast cancer.扩散峰度成像在术前乳腺癌 MRI 检查中对已知乳腺癌患者的额外可疑病变的鉴别诊断
Magn Reson Imaging. 2019 Oct;62:199-208. doi: 10.1016/j.mri.2019.07.011. Epub 2019 Jul 16.
5
Early prediction of response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and gray-scale ultrasonography.利用扩散加权成像和灰阶超声对乳腺癌患者新辅助化疗反应进行早期预测
Oncol Rep. 2014 Apr;31(4):1555-60. doi: 10.3892/or.2014.3025. Epub 2014 Feb 18.
6
MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy.磁共振成像测量肿瘤大小及药代动力学参数作为接受新辅助蒽环类化疗的乳腺癌患者反应的早期预测指标。
J Magn Reson Imaging. 2007 Sep;26(3):615-23. doi: 10.1002/jmri.21060.
7
Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.对接受新辅助化疗的局部晚期乳腺癌患者进行MRI及弥散加权成像评估肿瘤反应的纵向研究。
NMR Biomed. 2009 Jan;22(1):104-13. doi: 10.1002/nbm.1245.
8
MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study.磁共振成像纹理分析在鉴别管腔A型和管腔B型乳腺癌分子亚型中的应用——一项可行性研究
BMC Med Imaging. 2017 Dec 29;17(1):69. doi: 10.1186/s12880-017-0239-z.
9
Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.弥散加权磁共振成像在局部进展期乳腺癌新辅助化疗患者治疗前预测和疗效监测中的应用。
Acta Oncol. 2010 Apr;49(3):354-60. doi: 10.3109/02841861003610184.
10
Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer.研究3T多参数磁共振成像在乳腺癌新辅助化疗反应中的预测价值。
Eur Radiol. 2017 May;27(5):1901-1911. doi: 10.1007/s00330-016-4565-2. Epub 2016 Sep 20.

引用本文的文献

1
Radiomic analysis reveals diverse prognostic and molecular insights into the response of breast cancer to neoadjuvant chemotherapy: a multicohort study.基于放射组学分析揭示乳腺癌新辅助化疗反应的预后和分子特征:一项多队列研究。
J Transl Med. 2024 Jul 8;22(1):637. doi: 10.1186/s12967-024-05487-y.
2
A non-invasive artificial intelligence model for identifying axillary pathological complete response to neoadjuvant chemotherapy in breast cancer: a secondary analysis to multicenter clinical trial.一种用于识别乳腺癌新辅助化疗腋窝病理完全缓解的无创人工智能模型:多中心临床试验的二次分析。
Br J Cancer. 2024 Sep;131(4):692-701. doi: 10.1038/s41416-024-02726-3. Epub 2024 Jun 25.
3
Longitudinal ultrasound-based AI model predicts axillary lymph node response to neoadjuvant chemotherapy in breast cancer: a multicenter study.
基于纵向超声的人工智能模型预测乳腺癌新辅助化疗腋窝淋巴结反应:一项多中心研究。
Eur Radiol. 2024 Nov;34(11):7080-7089. doi: 10.1007/s00330-024-10786-5. Epub 2024 May 10.
4
Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.基于动态对比增强磁共振成像的Delta放射组学预测接受新辅助化疗的乳腺癌患者的病理完全缓解
Cancers (Basel). 2022 Jul 20;14(14):3515. doi: 10.3390/cancers14143515.
5
Radiomics of Tumor Heterogeneity in Longitudinal Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer.纵向动态对比增强磁共振成像中肿瘤异质性的放射组学用于预测乳腺癌新辅助化疗反应
Front Mol Biosci. 2021 Mar 22;8:622219. doi: 10.3389/fmolb.2021.622219. eCollection 2021.